Neurotechnology involves the study and interaction with the nervous system, encompassing the brain and other components of the nervous system. In clinical settings, neurotechnology is utilized to influence the brain or nervous system, often in therapeutic or rehabilitative contexts.
The primary neurotechnology applications include addressing conditions such as cognitive disorders, pain treatment, urinary and fecal incontinence, epilepsy, Parkinson's disease, hearing conditions, sleep disorders, depression, and various others. Cognitive disorders signify a significant decline in an individual's cognitive function to an extent that, without treatment, regular social activities become challenging. The diverse types of neurotechnology include imaging modalities, neurostimulation, cranial surface measurement, neurological implants, and others. These technologies find application in ambulatory surgical centers, hospitals, homecare facilities, and other medical settings.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The neurotechnology market research report is one of a series of new reports from The Business Research Company that provides neurotechnology market statistics, including neurotechnology industry global market size, regional shares, competitors with a neurotechnology market share, detailed neurotechnology market segments, market trends and opportunities, and any further data you may need to thrive in the neurotechnology industry. This neurotechnology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The neurotechnology market size has grown rapidly in recent years. It will grow from $15.38 billion in 2024 to $17.34 billion in 2025 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to increased research funding, aging population, neurological disorders prevalence, regulatory support, government initiatives.
The neurotechnology market size is expected to see rapid growth in the next few years. It will grow to $29.56 billion in 2029 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to regulatory advancements, genomics and neurological disorders, telemedicine in neurology, precision medicine adoption, development of closed-loop systems. Major trends in the forecast period include neuroinformatics advancements, neuroplasticity interventions, brain mapping initiatives, remote monitoring solutions, non-invasive brain stimulation.
The forecast of 14.3% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of brain-computer interface (BCI) systems by inflating prices of neural implants and signal processing modules developed in Switzerland and South Korea, resulting in slower rehabilitation for paralysis patients and higher neurorehabilitation costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The anticipated increase in the prevalence of neurological conditions is set to drive the growth of the neurotechnology market in the coming years. Neurological conditions encompass various disorders or diseases affecting the brain, including Alzheimer's disease, Parkinson's disease, epilepsy, and migraine. Neurotechnology is playing a crucial role in diagnosing and treating these conditions through methods such as brain imaging, neurostimulation, neurofeedback, and brain-computer interfaces. For example, as of January 2022, the American Heart Association Inc. projected that Alzheimer's disease and related dementias would impact approximately 9.3 million people in the United States by 2060. Additionally, according to the World Health Organization (WHO) in February 2023, an estimated 5 million people worldwide are expected to be diagnosed with epilepsy annually. Therefore, the increasing prevalence of neurological conditions is a driving force behind the growth of the neurotechnology market.
The increasing healthcare expenditure is expected to propel the growth of the neurotechnology market in the coming years. Healthcare expenditure refers to the total spending on healthcare-related goods and services within a particular healthcare system or economy. This spending supports the development and implementation of neurotechnology by promoting research, improving access to advanced equipment, enhancing education and training, facilitating clinical trials, ensuring regulatory oversight, and making innovative treatments more accessible for patients requiring neurological care. For instance, in 2022, the Office for National Statistics, a UK-based national statistics organization, reported that UK healthcare expenditure reached approximately $354.88 billion (£283 billion), representing a nominal increase of 0.7% compared to the previous year. Thus, the rise in healthcare expenditure is driving the growth of the neurotechnology market.
Technological advancements represent a significant trend gaining momentum in the neurotechnology market, with companies adopting innovative technologies to maintain their market positions. For instance, in November 2022, Blackrock Neurotech, a biotechnology company based in the United States, introduced Neuralace, a next-generation technology in neurotechnology. Neuralace, resembling a lace thinner than an eyelash, can cover large areas of the brain's surface. Designed as an ultra-high channel count, flexible electrode, Neuralace provides insights into the technology powering future brain-computer interfaces (BCIs). The system assists patients in regaining tactile function, limb and prosthetic movement, and the ability to control digital devices.
Major players in the neurotechnology market are concentrating on developing advanced therapeutic solutions, including the endovascular brain-computer interface (BCI), to enhance cognitive function and restore mobility for patients with neurological impairments. The endovascular BCI allows for direct neural access through blood vessels, enabling better interaction and treatment options for individuals with neurological disorders. For instance, in April 2024, Synchron, a Sweden-based software company specializing in advanced synchronization technologies for seamless data integration and management, launched the Patient Registry for its Stentrode Brain-Computer Interface. This technology is designed to interpret brain signals and restore motor intent, allowing individuals with limited mobility to control digital devices hands-free. Implanted via a non-invasive endovascular procedure, it wirelessly transmits motor intent from the brain, helping severely paralyzed patients regain independence. This groundbreaking technology marks a significant advancement in assistive solutions, facilitating daily activities such as communication and access to essential services.
In April 2022, Blackrock Neurotech, a U.S.-based biotechnology company, acquired Mindx Corporation for an undisclosed amount. This acquisition expands Blackrock's software portfolio and positions the company to offer integrated BCI products with cutting-edge features, enhancing its ability to provide a full-stack solution to customers. Mindx Corporation, based in the United States, is known for developing a neuron technology framework for use in spatial computing applications.
Major companies operating in the neurotechnology market include General Electric, Medtronic PLC, Koninklijke Philips N.V., Shimadzu Corporation, EndoStim Inc., Elekta AB, Natus Medical Incorporated, Abbott, Boston Scientific Corporation, Cleveland Medical Devices Inc., Nihon Kohden Corporation, LivaNova PLC, Siemens Healthcare Private Limited, Hitachi Medical Corporation, Cochlear Limited, Advanced Bionics AG (Sonova), NeuroPace Inc., NeuroSigma Inc., NeuroMetrix Inc., NeuroSky Inc., NeuroVigil Inc., Neurotech Pharmaceuticals Inc., Neurotech International Limited, NeurotechEU, Neurotech Solutions, Neurotech Reports, Neurotech Research Development
North America was the largest region in the neurotechnology market in 2024. Europe is expected to be the fastest-growing region in the neurotechnology market report during the forecast period. The regions covered in the neurotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the neurotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The neurotechnology market includes revenues earned by entities from neuro-rehabilitative treatment, heart rate variability, electroencephalography, and neurostimulation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The neurotechnology market consists of sales of brain-computer interfaces (BCIs), neurostimulation devices, virtual reality (VR), and prosthetic limb devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Neurotechnology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on neurotechnology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for neurotechnology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurotechnology market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Conditions: Cognitive Disorders; Pain Treatment; Urinary And Faecal Incontinence; Epilepsy; Parkinson's Disease; Hearing Conditions; Sleep Disorder; Depression; Other Conditions
- 2) By Type: Imaging Modalities; Neurostimulation; Cranial Surface Measurement; Neurological Implants; Other Types
- 3) By End Use: Ambulatory Surgical Centers; Hospitals; Homecare Facilities; Other End Uses
- Subsegments:
- 1) By Cognitive Disorders: Alzheimer's Disease; Attention Deficit Hyperactivity Disorder (ADHD); Dementia
- 2) By Pain Treatment: Chronic Pain; Neuropathic Pain; Acute Pain
- 3) By Urinary And Fecal Incontinence: Overactive Bladder; Neurogenic Bladder; Fecal Incontinence Management
- 4) By Epilepsy: Drug-Resistant Epilepsy; Seizure Management Devices
- 5) By Parkinson's Disease: Motor Symptoms Management; Non-Motor Symptoms Management
- 6) By Hearing Conditions: Tinnitus; Hearing Loss Solutions
- 7) By Sleep Disorder: Insomnia; Sleep Apnea; Restless Legs Syndrome
- 8) By Depression: Major Depressive Disorder; Treatment-Resistant Depression
- 9) By Other Conditions: Anxiety Disorders; Autism Spectrum Disorder; Traumatic Brain Injury (TBI)
- Companies Mentioned: General Electric; Medtronic PLC; Koninklijke Philips N.V.; Shimadzu Corporation; EndoStim Inc.; Elekta AB; Natus Medical Incorporated; Abbott; Boston Scientific Corporation; Cleveland Medical Devices Inc.; Nihon Kohden Corporation; LivaNova PLC; Siemens Healthcare Private Limited; Hitachi Medical Corporation; Cochlear Limited; Advanced Bionics AG (Sonova); NeuroPace Inc.; NeuroSigma Inc.; NeuroMetrix Inc.; NeuroSky Inc.; NeuroVigil Inc.; Neurotech Pharmaceuticals Inc.; Neurotech International Limited; NeurotechEU; Neurotech Solutions; Neurotech Reports; Neurotech Research Development
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Neurotechnology Market Characteristics
3. Neurotechnology Market Trends And Strategies
4. Neurotechnology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Neurotechnology Growth Analysis And Strategic Analysis Framework
- 5.1. Global Neurotechnology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Neurotechnology Market Growth Rate Analysis
- 5.4. Global Neurotechnology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Neurotechnology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Neurotechnology Total Addressable Market (TAM)
6. Neurotechnology Market Segmentation
- 6.1. Global Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cognitive Disorders
- Pain Treatment
- Urinary And Faecal Incontinence
- Epilepsy
- Parkinson's Disease
- Hearing Conditions
- Sleep Disorder
- Depression
- Other Conditions
- 6.2. Global Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Imaging Modalities
- Neurostimulation
- Cranial Surface Measurement
- Neurological Implants
- Other Types
- 6.3. Global Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Ambulatory Surgical Centers
- Hospitals
- Homecare Facilities
- Other End Uses
- 6.4. Global Neurotechnology Market, Sub-Segmentation Of Cognitive Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Alzheimer's Disease
- Attention Deficit Hyperactivity Disorder (ADHD)
- Dementia
- 6.5. Global Neurotechnology Market, Sub-Segmentation Of Pain Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chronic Pain
- Neuropathic Pain
- Acute Pain
- 6.6. Global Neurotechnology Market, Sub-Segmentation Of Urinary And Fecal Incontinence, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Overactive Bladder
- Neurogenic Bladder
- Fecal Incontinence Management
- 6.7. Global Neurotechnology Market, Sub-Segmentation Of Epilepsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Drug-Resistant Epilepsy
- Seizure Management Devices
- 6.8. Global Neurotechnology Market, Sub-Segmentation Of Parkinson's Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Motor Symptoms Management
- Non-Motor Symptoms Management
- 6.9. Global Neurotechnology Market, Sub-Segmentation Of Hearing Conditions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tinnitus
- Hearing Loss Solutions
- 6.10. Global Neurotechnology Market, Sub-Segmentation Of Sleep Disorder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Insomnia
- Sleep Apnea
- Restless Legs Syndrome
- 6.11. Global Neurotechnology Market, Sub-Segmentation Of Depression, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Major Depressive Disorder
- Treatment-Resistant Depression
- 6.12. Global Neurotechnology Market, Sub-Segmentation Of Other Conditions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Anxiety Disorders
- Autism Spectrum Disorder
- Traumatic Brain Injury (TBI)
7. Neurotechnology Market Regional And Country Analysis
- 7.1. Global Neurotechnology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Neurotechnology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Neurotechnology Market
- 8.1. Asia-Pacific Neurotechnology Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Neurotechnology Market
- 9.1. China Neurotechnology Market Overview
- 9.2. China Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Neurotechnology Market
- 10.1. India Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Neurotechnology Market
- 11.1. Japan Neurotechnology Market Overview
- 11.2. Japan Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Neurotechnology Market
- 12.1. Australia Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Neurotechnology Market
- 13.1. Indonesia Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Neurotechnology Market
- 14.1. South Korea Neurotechnology Market Overview
- 14.2. South Korea Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Neurotechnology Market
- 15.1. Western Europe Neurotechnology Market Overview
- 15.2. Western Europe Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Neurotechnology Market
- 16.1. UK Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Neurotechnology Market
- 17.1. Germany Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Neurotechnology Market
- 18.1. France Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Neurotechnology Market
- 19.1. Italy Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Neurotechnology Market
- 20.1. Spain Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Neurotechnology Market
- 21.1. Eastern Europe Neurotechnology Market Overview
- 21.2. Eastern Europe Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Neurotechnology Market
- 22.1. Russia Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Neurotechnology Market
- 23.1. North America Neurotechnology Market Overview
- 23.2. North America Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Neurotechnology Market
- 24.1. USA Neurotechnology Market Overview
- 24.2. USA Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Neurotechnology Market
- 25.1. Canada Neurotechnology Market Overview
- 25.2. Canada Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Neurotechnology Market
- 26.1. South America Neurotechnology Market Overview
- 26.2. South America Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Neurotechnology Market
- 27.1. Brazil Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Neurotechnology Market
- 28.1. Middle East Neurotechnology Market Overview
- 28.2. Middle East Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Neurotechnology Market
- 29.1. Africa Neurotechnology Market Overview
- 29.2. Africa Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Neurotechnology Market Competitive Landscape And Company Profiles
- 30.1. Neurotechnology Market Competitive Landscape
- 30.2. Neurotechnology Market Company Profiles
- 30.2.1. General Electric Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Shimadzu Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. EndoStim Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Neurotechnology Market Other Major And Innovative Companies
- 31.1. Elekta AB
- 31.2. Natus Medical Incorporated
- 31.3. Abbott
- 31.4. Boston Scientific Corporation
- 31.5. Cleveland Medical Devices Inc.
- 31.6. Nihon Kohden Corporation
- 31.7. LivaNova PLC
- 31.8. Siemens Healthcare Private Limited
- 31.9. Hitachi Medical Corporation
- 31.10. Cochlear Limited
- 31.11. Advanced Bionics AG (Sonova)
- 31.12. NeuroPace Inc.
- 31.13. NeuroSigma Inc.
- 31.14. NeuroMetrix Inc.
- 31.15. NeuroSky Inc.
32. Global Neurotechnology Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Neurotechnology Market
34. Recent Developments In The Neurotechnology Market
35. Neurotechnology Market High Potential Countries, Segments and Strategies
- 35.1 Neurotechnology Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Neurotechnology Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Neurotechnology Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
